{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:40:42Z","timestamp":1761486042282,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpurol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pediatric Urology"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.jpurol.2007.05.007","type":"journal-article","created":{"date-parts":[[2007,8,3]],"date-time":"2007-08-03T07:18:26Z","timestamp":1186125506000},"page":"438-442","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Treatment with modified intravesical oxybutynin chloride for neurogenic bladder in children"],"prefix":"10.1016","volume":"3","author":[{"given":"Atsushi","family":"Hayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoaki","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ichi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Hanada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Kanzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpurol.2007.05.007_bib1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0022-5347(17)36663-6","article-title":"The pharmacokinetics of intravesical and oral oxybutynin chloride","volume":"148","author":"Massad","year":"1992","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2007.05.007_bib2","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0022-5347(01)62828-3","article-title":"Intravesical oxybutynin for neurogenic bladder dysfunction: less systematic side effects due to reduced first pass metabolism","volume":"160","author":"Buyse","year":"1998","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2007.05.007_bib3","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S0022-5347(17)41304-8","article-title":"Topical oxybutynin chloride for relaxation of dysfunctional bladders","volume":"141","author":"Brendler","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2007.05.007_bib4","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0022-5347(17)37845-X","article-title":"The use of intravesical oxybutynin chloride in children with neurogenic bladder","volume":"146","author":"Greenfield","year":"1991","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2007.05.007_bib5","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/1520-6777(2000)19:6<683::AID-NAU6>3.0.CO;2-R","article-title":"Treatment of overactive bladder with modified intravesical oxybutynin chloride","volume":"19","author":"Saito","year":"2000","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.jpurol.2007.05.007_bib6","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1442-2042.2004.00871.x","article-title":"Urodynamic effects and safety of modified intravesical oxybutynin chloride in patients with neurogenic detrusor overactivity: 3 years experience","volume":"1","author":"Saito","year":"2004","journal-title":"Int J Urol"},{"key":"10.1016\/j.jpurol.2007.05.007_bib7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000019701","article-title":"Follow-up of long time treatment with intravesical oxybutynin for neurogenic bladder children","volume":"34","author":"Amark","year":"1998","journal-title":"Eur Urol"},{"key":"10.1016\/j.jpurol.2007.05.007_bib8","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S0022-5347(17)35130-3","article-title":"The use of intravesical oxybutynin chloride in patients with detrusor hyperactivity and detrusor hyperreflexia","volume":"151","author":"Kasabian","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2007.05.007_bib9","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0022-5347(01)65238-8","article-title":"Complications of intravesical oxybutynin chloride therapy in the pediatric myelomeningocele population","volume":"157","author":"Palmer","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.jpurol.2007.05.007_bib10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/sj.sc.3101584","article-title":"Intravesical therapy options for neurogenic detrusor overactivity","volume":"42","author":"Reitz","year":"2004","journal-title":"Spinal Cord"},{"key":"10.1016\/j.jpurol.2007.05.007_bib11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.urology.2003.11.003","article-title":"Management of detrusor dysfunction in the elderly: changes in acetylcholine and adenosine triphosphate release during aging","volume":"63","author":"Yoshida","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.jpurol.2007.05.007_bib12","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1152\/jn.2000.84.4.1934","article-title":"M2-receptor subtype does not mediate muscarine-induced increases in Ca(2+)(i) in nociceptive neurons of rat dorsal root ganglia","volume":"84","author":"Haberberger","year":"2000","journal-title":"J\u00a0Neurophysiol"},{"key":"10.1016\/j.jpurol.2007.05.007_bib13","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.eururo.2006.06.024","article-title":"Ability of cyclohexenonic long-chain fatty alcohol to reverse diabetes induced cystopathy in the rats","volume":"51","author":"Saito","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.jpurol.2007.05.007_bib14","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.urology.2004.11.021","article-title":"Antimuscarinic agents exhibit local inhibitory effects on muscarinic receptors in bladder afferent pathways","volume":"65","author":"Kim","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.jpurol.2007.05.007_bib15","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0090-4295(93)90098-U","article-title":"Intravesical oxybutynin chloride: experience with 42 patients","volume":"41","author":"Weese","year":"1993","journal-title":"Urology"},{"key":"10.1016\/j.jpurol.2007.05.007_bib16","first-page":"306","article-title":"New intravesical oxybutynin hydrochloride used for the treatment of neurogenic bladder dysfunction","volume":"15","author":"Mizunaga","year":"1996","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.jpurol.2007.05.007_bib17","first-page":"368","article-title":"Relationship of asymptomatic bacteriuria and renal scarring in children with neurogenic bladders who are practicing clean intermittent self-catheterization","volume":"157","author":"Ottolini","year":"1995","journal-title":"J Urol"}],"container-title":["Journal of Pediatric Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513107003683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477513107003683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:34:21Z","timestamp":1761485661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477513107003683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S1477513107003683"],"URL":"https:\/\/doi.org\/10.1016\/j.jpurol.2007.05.007","relation":{},"ISSN":["1477-5131"],"issn-type":[{"type":"print","value":"1477-5131"}],"subject":[],"published":{"date-parts":[[2007,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment with modified intravesical oxybutynin chloride for neurogenic bladder in children","name":"articletitle","label":"Article Title"},{"value":"Journal of Pediatric Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpurol.2007.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Journal of Pediatric Urology Company. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}